BEL113750
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BEL113750, covering 2020-01-09 to 2020-01-09. Get the full timeline:
Most recent: Clinical Trial Update: BEL114333, a Continuation Study of BEL113750 in Subjects With Systemic Lupus Erythematosus (SLE) in Northeast Asia, and in Japan Subjects Completing the Open-label Extension of HGS1006-C1115 [Phase 3]